 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Mar 22, 2004 |
| Title |
Gene expression data from stained liver Control4 |
| Sample type |
RNA |
| |
|
| Source name |
stained liver sections from untreated rats
|
| Organism |
Rattus norvegicus |
| Extracted molecule |
total RNA |
| |
|
| Description |
Liver sections from F344 rats treated with Clofibric Acid (CA) (0, 0.29 or 0.54 %)
Keywords = Laser Capture Microdissection, Clofibric-Acid
|
| |
|
| Submission date |
Oct 01, 2003 |
| Last update date |
May 28, 2005 |
| Contact name |
Cecile Michel |
| E-mail(s) |
[email protected]
|
| Phone |
0(0 33)1 58 93 35 76
|
| Organization name |
Aventis Pharma France
|
| Department |
Drug Safety Evaluation
|
| Lab |
Toxicogenomic
|
| Street address |
13, quai Jules Guesdes
|
| City |
Vitry sur Seine |
| ZIP/Postal code |
94403 |
| Country |
France |
| |
|
| Platform ID |
GPL85 |
| Series (1) |
| GSE691 |
Expression Profiles of Rats Treated with Clofibric Acid: Comparison of Whole and Laser Capture Microdissected Liver |
|
| Data table header descriptions |
| ID_REF |
|
| VALUE |
'signal' a measure of the abundance of a transcript |
| ABS_CALL |
the call in an absolute analysis that indicates if the transcript was present (P), absent (A), marginal (M), or no call (NC) |
| Data table |
| ID_REF |
VALUE |
ABS_CALL |
| affx-muril2_at |
-12 |
A |
| affx-muril10_at |
-2 |
A |
| affx-muril4_at |
-6 |
A |
| affx-murfas_at |
2 |
A |
| affx-biob-5_at |
253 |
P |
| affx-biob-m_at |
582 |
P |
| affx-biob-3_at |
364 |
P |
| affx-bioc-5_at |
795 |
P |
| affx-bioc-3_at |
882 |
P |
| affx-biodn-5_at |
745 |
P |
| affx-biodn-3_at |
3143 |
P |
| affx-crex-5_at |
4412 |
P |
| affx-crex-3_at |
9051 |
P |
| affx-biob-5_st |
44 |
P |
| affx-biob-m_st |
11 |
A |
| affx-biob-3_st |
12 |
A |
| affx-bioc-5_st |
-6 |
A |
| affx-bioc-3_st |
-6 |
A |
| affx-biodn-5_st |
65 |
A |
| affx-biodn-3_st |
40 |
A |
Total number of rows: 8799
Table truncated, full table size 158 Kbytes.
| Supplementary data files not provided |
|
|
|
|
 |
